Identity
- Trade Name
- SAHARA-III basic model 115V FDA UDI
- Generic Name
- Cryopreserved blood/tissue thawing unit FDA UDI
- Model / Reference
- 97.8710.502 FDA UDI
Identifiers
- Catalog Number
- 97.8710.502 FDA UDI
- Primary DI / UDI-DI
- 04038917968324 FDA UDI
- FDA Product Code
- KZL FDA UDI
- GMDN Term
- Cryopreserved blood/tissue thawing unit FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 864.9205 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Cryopreserved blood/tissue thawing unit
SAHARA-III basic model 115V by Sarstedt Aktiengesellschaft & Co.KG — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Cryopreserved blood/tissue thawing unit.
- CytoTherm — CYTOTHERM LP · Class II
- CytoTherm — CYTOTHERM LP · Class II
- CytoTherm — CYTOTHERM LP · Class II
- ZipThaw™ 202 — FREMON SCIENTIFIC INC · Class II
- QuickThaw® — HELMER Inc. · Class I
- CytoTherm — CYTOTHERM LP · Class II
- CytoTherm — CYTOTHERM LP · Class II
- SAHARA — Transmed Medizintechnik GmbH & Co. KG · Class II
Cleared under the same submission
BK010045 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Sarstedt Aktiengesellschaft & Co.KG
Sources (1)
- FDA UDI ea53c9f8-8aef-49ea-bc7d-ba30d81fcfce 35 fields · synced Jun 6, 2026